PYC Therapeutics Limited Price (PYC.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

3,935,910,623

(21.1491)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $1.03-2
  • Market Cap 723.24M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Dr. Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.)
  • IPO Date: March, 30, 2005
  • Country: AU
  • Currency: AUD
  • Headquaters: Nedlands, WA
  • Employees: 23

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation